Chelation therapy for atherosclerotic cardiovascular disease-Reference-Cited by-同舟云学术

Chelation therapy for atherosclerotic cardiovascular disease

Published:2020-05-05 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Villarruz-Sulit Maria Vanessa¹,Forster Rachel²,Dans Antonio L³,Tan Flordeliza N⁴,Sulit Dennis V⁵

Affiliation:

1. Asia-Pacific Center for Evidence-Based Healthcare; Ermita, Manila Philippines

2. Usher Institute; University of Edinburgh; Edinburgh UK

3. Section of Adult Medicine, College of Medicine; University of the Philippines; Ermita Philippines

4. Emergency Department; Montefiore Westchester Square Campus; New York USA

5. Department of Internal Medicine; Cardinal Santos Medical Center; San Juan City, Metro Manila Philippines

Publisher

Wiley

Subject

Pharmacology (medical)

Reference62 articles.

1. Disodium-ethylene diamine tetraacetic acid (EDTA) has no effect on blood lipids in atherosclerotic patients. A randomized, placebo-controlled study;Guldager;Danish Medical Bulletin,1993

2. EDTA treatment of intermittent claudication - a double-blind, placebo-controlled study;Guldager;Journal of Internal Medicine,1992

3. EDTA versus placebo treatment in intermittent claudication. A double-blind randomized trial;Guldager;Ugeskrift for Laeger,1992

4. Metal excretion and magnesium retention in patients with intermittent claudication treated with intravenous disodium EDTA;Guldager;Clinical Chemistry,1996

5. Arteriographic findings in EDTA chelation therapy on peripheral arteriosclerosis;Sloth-Nielsen;American Journal of Surgery,1991

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chelation Therapy Following Myocardial Infarction;JAMA;2024-09-10

2. 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Circulation;2024-06-11

3. 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease;Journal of the American College of Cardiology;2024-06

4. Heavy Metal Exposure and Cardiovascular Disease;Circulation Research;2024-04-26

5. Copper homeostasis and cuproptosis in atherosclerosis: metabolism, mechanisms and potential therapeutic strategies;Cell Death Discovery;2024-01-13